Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | FS120 |
Synonyms | |
Therapy Description |
FS120 is a bispecific antibody that targets TNFRSF9 (4-1BB, CD137) and TNFRSF4 (OX40, CD134), which may lead to enhanced anti-tumor immune response (NCI Thesaurus). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
FS120 | FS-120|FS 120 | TNFRSF9 Antibody 30 | FS120 is a bispecific antibody that targets TNFRSF9 (4-1BB, CD137) and TNFRSF4 (OX40, CD134), which may lead to enhanced anti-tumor immune response (NCI Thesaurus). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04648202 | Phase I | FS120 | FS120 First in Human Study in Patients With Advanced Malignancies | Recruiting | USA | ESP | 0 |